Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Intro to Pharmacology > NSAIDS #2 > Flashcards

NSAIDS #2 Flashcards

1
Q

How are NSAIDs classified?

A
  1. Inhibitors of Prostanoids (PGs, TXA2)
  2. Miscellaneous Anti-Inflammatory Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs: Mechanisms of Action

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs: Adverse Effects

A

High doses
Long exposure
▪ Vomiting
▪ Diarrhea
**▪ GI ulceration, hemorrhage, and perforation
▪ Hepatotoxicity
▪ Renal toxicity
▪ Cardiovascular and blood toxicity
▪ CNS depression
▪ Circulatory disturbances
▪ Drug-drug interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NSAIDs that are used most commonly in humans can cause poisoning in small animals are?

A

Aspirin
Acetaminophen
Ibuprofen
Indomethacin
Naproxen

Pneumonic: IIAN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the Desirable Features of NSAIDs
▪ Deactivate/desensitize _________ (_____)
▪ Attenuate ___________ response
▪ Synergistic with _______
▪ No ___________ or __________
▪ No ____________ depression
▪ Minimal ?
▪ ____ duration of action
▪ No ________ side effects

A

nociceptors, pain, inflammatory, opioids, addiction, dependence, respiratory, nausea/vomiting, Long, cognitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COX-1 mediates ?

A

physiological responses (GI protection, platelet aggregation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COX-2 is expressed by cells involved in ____________ (e.g.?) is responsible for
the synthesis of _____ and _____

A

inflammation, macrophages, monocytes, PGs, TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Selective inhibition of COX-2 might have ?

A

better therapeutic responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Selectivity of COX2 versus COX1 is often expressed as the?

A

COX1/COX2 inhibitory ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Write the inhibitory effect ratio.

If ratio is > _____, the drug is more specific for COX-2.

A

The inhibitory effect (IC50) = COX-1/COX-2;
COX-1/COX-2 >1, the drug is more specific for COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COX-1 _______
COX-1 ______ ( _____ selective)
COX-2 _____
COX-2 _______
COX-2 ________ (______ selectivity)

A

selective, sparing, Non, specific, selective, preferential, limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Potential benefits in inhibiting LOX pathway:

A

▪ Higher GI safety
▪ Greater analgesic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the examples of Dual inhibitors:

A

Benoxaprofen
Ketoprofen
Licofelone
Corticosteroids (adverse effects)
Tepoxalin (Zubrin) is approved in Europe and USA
in animals (osteoarthritis in dogs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the NSAIDs that fall under the category of the following:

  1. Selective COX-1 inhibitor
  2. Non-selective COX inhibitors
  3. Selective COX-2 Inhibitors
  4. Dual Inhibitors - COX/LOX
A

See below

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Selective COX-1 Inhibitors

A

Low-dose Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Non-selective COX Inhibitors

A

FAKIN

  • Naproxen (AleveR)
  • Ibuprofen (MotrinR, AdvilR)
  • Ketoprofen ((AnafenR)
  • Aspirin
  • Flunixin meglumine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Selective-COX-2 Inhibitors

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dual Inhibitors COX / LOX

A

Tepoxalin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Adverse effects of NSAIDs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NS –> Aspirin - Dogs

A

Aspirin is not USDA –registered for dogs, but some forms are marketed
for dogs as if there were FDA approval. There is an approved combination
with methylprednisolone (Cortaba tablets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

COX-2 Inh for dogs?

A

Pneumonic:

Christine Eats Many Penises

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

______________ is Registered for dogs but not actively marketed

A

Phenylbutazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Carprofen (________) Available as an ____________ and ____ (COX-___ sparing in dogs)

A

Rimadyl, injectable, oral, 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Meloxicam (_______) is Registered for cats also as a ___ dose, available as an _____ and __

A

Metacam, single, injectable, oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

The NS Ketoprofen (Anafen) is registered for ?

A

cats only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Deracoxib (_________) is (COX-__ ______, first veterinary drug in this group)

A

Deramaxx, 2, specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

_________ _______ (Arquel) is _______ but not marketed

A

Meclofenamic acid, registered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

__________ ____ (Tolfedine) is registered in ______ only, available as an ______ and ___

A

Tolfenamic acid, Canada, injectable, oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Aspirin is a NSAID used to reduce?

A

Pain
Fever
Inflammation
Platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Aspirin: (low doses) prevents?

A

heart attacks and strokes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Salicylic acid from _____ ____ have been used for ____ relief since ancient times

A

willow, bark, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Modification of Salicylic acid to ______ ________ ______ (____) = Aspirin

A

Acetyl Salicylic Acid (ASA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Use of aspirin for pain and prevention of myocardial infarction
▪ Understanding the molecular mechanism of aspirin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Aspirin MOA

A

Aspirin irreversible inhibits COX-1 resulting in
decreased PG synthesis
decrease TXA2 expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Effects of Aspirin

A

Analgesic
Antipyretic
Anticoagulant: platelet aggregation reducer
Anti-inflammatory: PGs expression reducer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Asprin PK:
Absorption from the _____ and ___ intestine
Bound to _____ (70-90%)
_____ t1/2 in cats (~30 hrs); in dogs (~ 8 hrs); in horses (~ 5 hrs)
_____ are sensitive to aspirin toxicity _____ are sensitive to GI effects (bleeding)

A

stomach, upper, albumin, Long, Cats, Dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

______ are sensitive to aspirin toxicity

A

Cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

_____ are sensitive to GI effects (bleeding)

A

Dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Adverse effects of Asprin:
▪ GI distress: ?
▪ Paradoxical-_______ (body T above ______ F (____ C)
▪ _____ventilation, respiratory _____ (_____ depression)
▪ Metabolic ______
▪ ___________
▪ Pulmonary ______ (______)
▪ If chronic use —– _________ during surgery
▪ In dogs with _____, long-term use may result in aggravation of joint disease
▪ Drug-drug interaction (_______)

A

vomiting, anorexia, GI ulceration, diarrhea
hyperpyrexia, 106.70, 41.50, Hyper, acidosis, CNS, acidosis, Dehydration, edema, sheep, bleeding, OA, Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Treatment of aspirin-toxicity:
▪ Induce ______ in the case of ____ toxicity
▪ Increase _____ of the drug: gastric lavage followed by administration of activated _____
▪ Increase _____ excretion of aspirin by administrating an ______ agent
▪ Initiate IV ___ therapy to address _____ and metabolic ______

A

emesis, acute, removal, charcoal, urinary, alkalinizing, fluid, dehydration, acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Aspirin
Contraindications: Patients with _____ GI ______; _______ disorders, _____, or _____ insufficiency

A

active, bleeds, bleeding, asthma, renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Flunixin meglumie AKA?

A

Banamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Flunixin: A _____-_________ COX inhibitor with potent __________ and ______-___________ effects

A

non-selective, analgesic, anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

MOA of Flunixin meglumine
MOA: Shows greater COX-2 inhibitory effects than COX-1 in _________-.
In _________-, it appears to exhibit preferential COX-1 inhibitory effect

A

MOA: Shows greater COX-2 inhibitory effects than COX-1 in horses.
In dogs, it appears to exhibit preferential COX-1 inhibitory effect

46
Q

Uses of Flunixin meglumine
Uses:
▪ For the treatment of ____, ______, and _______ pain
▪ Exceptional property: it alleviates ________ pain related to colic
▪ In horses: effective in producing the _________ duration of ________ analgesia (~ ___ hrs)
▪ In cattle: for the control of _________ associated with respiratory disease, _________ and _______ (____ approved by FDA)

A

Uses:
▪ For the treatment of acute, visceral, and surgical pain
▪ Exceptional property: it alleviates visceral pain related to colic
▪ In horses: effective in producing the longest duration of postoperative analgesia (~ 13 hrs)
▪ In cattle: for the control of pyrexia associated with respiratory disease,
endotoxemia and mastitis (not approved by FDA)

47
Q

PK for Flunixin meglumine
PK:
▪ Administered via what routes:
▪ IV: a plasma t1/2 of 2-4 hrs (______); 3-6 hrs (____); 4hrs (____);1-1.5 hrs (____)
▪ IV: Duration of action is ___-____ hrs
▪ _____ excretion

A

IV, IM, horses, cattle, dogs, cats, 24-36, Renal

48
Q

Adverse Effects - Flunixin Meglumine
Adverse effects:
▪ _________ with IM administration
▪ Overdose in horses: ulcers on the ?, _____ depression, _______ (rare)
▪ In dogs: _____ failure and ___ damage

A

Adverse effects:
▪ Myonecrosis with IM
▪ Overdose in horses: ulcers on the tongue, gingiva, lips, and stomach
CNS depression, anorexia (rare)
▪ In dogs: renal failure and GI damage

49
Q

Ketoprofen: A ____-_______ COX inhibitor with ___-_________ and _______ effects

A

non-selective, anti-inflammatory, analgesic

50
Q

Ketoprofen MOA

A

MOA: Inhibition of COX-1 and COX-2 and LOX-pathway ( LTB4 synthesis)

51
Q

List the uses of Ketoprofen
Uses: In horses:
▪ Acute and chronic ___________ disorders

PK:
▪ Admin routes?
▪ Excellent bioavailability of ___-___%
▪ _____ elimination t1/2 of ~ 1 hr (horses); 1.5 hrs (dogs and cats)
▪ _____ excretion

A

Uses: In horses:
▪ Acute and chronic musculoskeletal disorders
PK:
▪ IV, IM, SC or PO
▪ Excellent bioavailability of 80-100%
▪ Short elimination t1/2 of ~ 1 hr (horses); 1.5 hrs (dogs and cats)
▪ Renal excretion

52
Q

Adverse effects of Ketoprofen?

Adverse effects:
▪ Safer profile compared to _____ or _________
▪ PO: GI injury including ______ and ______
▪ Caution in animals with ________ disorders (decreased platelet _______)
▪ Caution in animals with compromised _____ function

A

flunixin, phenylbutazone, ulceration, bleeding, hemostatic, aggregation, renal

53
Q

Phenylbutazone: The _____ and _____ profile in addition to its _____
makes it the most commonly used NSAID in the ____

A

safety, efficacy, affordability, horse

54
Q

Phenylbutazone MOA
Preferential COX-___ inhibitor in both ____ and ___

A

MOA: Preferential COX-2 inhibitor in both horses and dogs

55
Q

Phenylbutazone Uses

A

Uses:
▪ Osteoarthritis
▪ Various forms of lameness
▪ Rheumatism
▪ Other painful conditions of the limbs
▪ Nonspecific inflammation in other conditions

56
Q

Phenylbutazone PK
PK:
▪ After IV administration, t1/2 is ____-_____ hrs in the dog and horse
▪ Long duration of action (___-___ hrs)
▪ ______ metabolite (___________)
▪ High ______ binding
▪ Elimination via ____ excretion (25%)

A

PK:
▪ After IV administration, t1/2 is 2,5 – 6 hrs in the dog and horse
▪ Long duration of action (24 -72 hrs)
▪ Active metabolite (oxyphenylbutazone)
▪ High albumin binding
▪ Elimination via renal excretion (25%)

57
Q

Adverse effects of Phenylbutazone
▪ GI distress: ?
▪ Renal papillary _______
▪ ________ (hypovolemic shock, ulcer-mediated sepsis)

A

Adverse effects:
▪ GI distress: erosions, ulcers, anorexia, colic, diarrhea
▪ Renal papillary necrosis
▪ Death (hypovolemic shock, ulcer-mediated sepsis

58
Q

Contraindications of Phenylbutazone

A

Contraindications: Patients with serious cardiac, renal, hepatic injury, or hematologic disorder

59
Q

Carprofen: preferential COX-___ inhibitor with _____ and ____-_____ effects

A

2, analgesic, anti-inflammatory

60
Q

Carprofen MOA
Potency of carprofen for canine COX-___ is more than ______- fold greater relative to canine COX-___

A

MOA: Potency of carprofen for canine COX-2 is more than 100- fold greater relative to canine COX-1

61
Q

Carprofen Uses
1. _____-term and _____-term pain management
2. ______________ disorders

A

Uses: Short-term and long-term pain management
▪ Musculoskeletal disorders

62
Q

Carprofen PK
▪ Administrated via ?
▪ PO: the Tmax is short or long?
▪ Highly bound to _______ (99%)
▪ ______ metabolism
▪ Eliminated in the _____ and ______
▪ Elimination t1/2 in cats: ?
in dogs: ?

A

PK:
▪ PO, IV or SC
▪ PO: the Tmax is 1-3 hrs (dogs) SHORT
▪ Highly bound to albumin (99%)
▪ Liver metabolism
▪ Eliminated in the feces/urine
▪ Elimination t1/2 in cats: ~ 20 hrs LONG
in dogs: ~ 5-7 hrs MIDDLE GROUND?

63
Q

Carofen adverse effects
▪ Lower frequency of GI ______ and ______
▪ ___________, __________, __________
▪ Caution in patients with _____ or ____ dysfunction

A

Adverse effects:
▪ Lower frequency of GI ulceration and hemorrhage
▪ Diarrhea, anorexia, vomiting
▪ Caution in patients with hepatic or renal dysfunction

64
Q

Carprofen contraindications

A

Contraindications: Patients with hemostatic disorders; pregnant, lactating, or breeding bitches

65
Q

Meloxicam aka?

A

Metacam

66
Q

Meloxicam: A preferential COX-______ inhibitor with __________ and ____-________ effects

A

2, analgesic, anti-inflammatory

67
Q

Meloxicam MOA

A

MOA: COX2/COX1 selectivity ratio of ~ 10

68
Q

Meloxicam Uses
Uses: For treatment of chronic ____ and ________
▪ _______________
▪ ______-operative ______ pain

A

Uses: For treatment of chronic pain and inflammation
▪ Osteoarthritis
▪ Post-operative somatic pain

69
Q

Meloxicam PK
▪ PO: ______ absorption, Tmax ~ ___ hrs
▪ _______ bound to albumin (97%)
▪ The plasma t1/2 is ______-specific: 12-24 hrs (____); 15 hrs (____); 3 hr (_______)
▪ ______ metabolism
▪ Elimination in the ____

A

PK:
▪ PO: good absorption, Tmax ~ 8 hrs
▪ Highly bound tp labumin (97%)
▪ The plasma t1/2 is species-specific: 12-24 hrs (dogs); 15 hrs (cats); 3 hr (horses)
▪ Liver metabolism
▪ Elimination in the feces

70
Q

Meloxicam Adverse effects
___________ safe NSAID in dogs and cats
▪ ___ distress
▪ _________
▪ _______

^ all of the above are ____ and _____

A

Adverse effects:
Relatively safe NSAID in dogs and cats
▪ GI distress
▪ Anemia
▪ lethargy
Rare and transient

71
Q

Repeated use of Meloxicam in cats can evoke ______ ______ failure and _____

A

Caution: Repeated use in cats can evoke acute renal failure and death

72
Q

Meloxicam contraindications

A

Contraindications: Not recommended in pregnant, lactating or in young animals (< 4 months)

73
Q

Meloxicam is FDA-approved in ______.

A

cats

74
Q

Etodolac: A preferential COX-____ inhibitor with ______ and ____-________ effects

A

2, analgesic, anti-inflammatory

75
Q

Etodolac MOA

A

?

76
Q

Etodolac AKA

A

EtoGesic

77
Q

Etodolac Uses
▪ _____________ in dogs
▪ Other conditions

A

▪ Osteoarthritis in dogs
▪ Other conditions

78
Q

Etodolac PK
▪ PO: ______ absorption and a _____
onset of action (30-60 min)
▪ Is the half life long or short?
▪ ____ excretion

A

▪ PO: Rapid absorption and a rapid
onset of action (30-60 min)
▪ Long plasma t1/2 : 10-14 hrs
▪ Bile excretion

79
Q

Etodolac Adverse effects:
____ distress
______ depression
______totoxicity
_______toxicity
May induce ________________ _____ in dogs (monitor ____ production)

A

GI distress , CNS depression, hepatotoxicity, nephrotoxicity
May induce keratoconjunctivitis sicca in dogs (monitor tear production)

80
Q

Etodolac caution

A

Caution: In patients with hematological, renal, or hepatic impairment

81
Q

Tepoxalin: _____ inhibitor: _____-_______ COX inhibitor plus potent inhibitory effect on _____

A

Dual, non-selective, LOX

82
Q

Tepoxalin AKA

A

Zubrin

83
Q

Tepoxalin MOA
MOA: inhibition of COX-__, COX-___, and ___-LOX
reduction of the production of ____ mediators of pain, fever, and inflammation

A

MOA: inhibition of COX-1, COX-2, and 5-LOX
reduction of the production of PG mediators of pain, fever, and inflammatio

84
Q

Tepoxalin uses
▪ __________ in dogs
▪ _______ conditions in dogs
▪ ____- operative pain control

A

▪ Osteoarthritis in dogs
▪ Allergic conditions in dogs
▪ Postoperative pain control

85
Q

Tepoxalin PK
▪ Readily absorbed after _____
▪ _______ metabolized, one ____ metabolite, Both are highly bound to ______
▪ T1/2: __ hrs and __ hrs, respectively
▪ Elimination in the ______

A

▪ Readily absorbed after PO
▪ Rapidly metabolized, one active metabolite
▪ Both are highly bound to albumin
▪ T1/2: 2 hrs and 13 hrs, respectively
▪ Elimination in the feces

86
Q

Tepoxalin Adverse effects

A

▪ GI distress: vomiting, anorexia, diarrhea, ulceration
▪ CNS depression
▪ Hepatotoxicity
▪ Nephrotoxicity

87
Q

Deracoxib (DeramaxxR) Uses

A

▪ Osteoarthritis
▪ Post-operative pain and inflammation

88
Q

Deracoxib PK

▪ PO:
▪ _____ protein bound
▪ _____ excretion
▪ 20% may be excreted in the _____

A

▪ PO:
▪ Highly protein bound
▪ Bile excretion
▪ 20% may be excreted in the urine

89
Q

Deracoxib adverse effects

A

GI distress

90
Q

Firocoxib is also called ?

A

PrevicoxR, Equioxx

91
Q

Firocoxib uses?

A

Osteoarthritis

92
Q

Firocoxib PK
▪ The bioavailability: ~ 80% in _______
~ 40% in ___
▪ ______ protein bound
▪ _______ metabolism
▪ _____ excretion

A

▪ The bioavailability: ~ 80% in horses
~ 40% in dogs
▪ Highly protein bound
▪ Hepatic metabolism
▪ Fecal excretion

93
Q

Firocoxib adverse effects

A

▪ Diarrhea, mouth ulcers
▪ Excitation (rare)
^ horses

▪ Vacuolization in the brain
(high doses)
^ dogs

94
Q

Drugs that are rarely used in Veterinary Medicine

A

Non-selective COX Inhibitors:
Aspirin
Acetaminophen (TylenolR) ( particularly unsafe in cats)
(paracetamol)
Ibuprofen (Motrin, Advil)
Naproxen (Aleve) (used in horses to treat myositis, lameness)
Indomethacin

95
Q

Dimethyl sulfoxide (DMSO): a solvent for many _____, ____ and _____ compounds. It is clear, _____ to ____-yellow liquid, highly _______.

A

aromatic, organic, inorganic, colorless, straw, hygroscopic

96
Q

Dimethyl sulfoxide (DMSO) effects

A

▪ Anti-inflammatory: inhibits PG synthesis and traps free radicals
▪ Analgesic
▪ Skin penetrating
▪ Diuretic
▪ Anticholinesterase
▪ Weak antibacterial
▪ Weak antifungal

97
Q

Dimethyl sulfoxide (DMSO) PK
▪ Well absorbed after _______ application
▪ _________ & ______ distribution
▪ Primarily _____ excretion

A

▪ Well absorbed after topical application
▪ Extensive & rapid distribution
▪ Primarily renal excretion

98
Q

Dimethyl sulfoxide (DMSO) Uses
▪ _____ swelling (_________ trauma)
▪ Cerebral _____ & ______ (spinal cord trauma)
▪ _________ (urethral ________ in the cat)
▪ Superficial _____
▪ Skin _____
▪ Transient ______ conditions
▪ Edema of limbs resulting from _____
▪ _____ and _______ of mammary glands in the nursing bitch
▪ Severe __________ resulting from the extravascular injection of irritating drugs or lick granuloma

A

▪ Acute swelling (musculoskeletal trauma)
▪ Cerebral edema & paralysis (spinal cord trauma)
▪ Cystitis (urethral obstruction in the cat)
▪ Superficial burns
▪ Skin grafts
▪ Transient ischemic conditions
▪ Edema of limbs resulting from fractures
▪ Swelling and engorgement of mammary glands in the nursing bitch
▪ Severe inflammation resulting from the extravascular injection of irritating drugs or lick granuloma

99
Q

Dimethyl sulfoxide (DMSO) adverse effects
When used as labeled, it is _____
▪ Transient _____ effects
▪ High doses, long use —- ______
▪ IV: _______ and ________
▪ _____ and ____ damages, pulmonary ____
▪ CNS: _______, _________, ________

A

When used as labeled, it is safe
▪ Transient local effects
▪ High doses, long use —- myopia
▪ IV: hemolysis and hemoglobinuria
▪ Hepatic and renal damages, pulmonary edema
▪ CNS: sedation, coma, seizures

100
Q

OA is a degenerative joint disease that affects the dog’s spine and lower limbs leading
to stiffness and excruciating pain in the joint

A
101
Q

Synovial lining is a membrane surrounding each joint, SF
(synovial fluid) helps ensure smoot and easy body movement
Hyaluronic acid (HA) is a natural lubricant of the joints, part of
SF.

A
102
Q

Polysulfated glycosaminoglycan :

A

Disease-modifying osteoarthritis drugs (DMOADs)
(AdequanR) (PSGAG)

103
Q

PSGAG MOA
▪ PSGAG modulates clinical signs of ______ by indirectly promoting ______________ effect via different mechanism
▪ Improves joint articular function by having effects on _________ _____
▪ Anti-inflammatory: inhibition of _____ biosynthesis, ________ migration & ________ levels

A

▪ PSGAG modulates clinical signs of OA by indirectly promoting chondroprotective effect
via different mechanism
▪ Improves joint articular function by having effects on synovial fluid
▪ Anti-inflammatory: inhibition of PGE2 biosynthesis, leukocyte migration & interleukin levels

104
Q

PSGAG Uses

A

▪ To treat traumatic joint dysfunction (horses)
▪ To treat OA and prevent hip dysplasia (dogs)

105
Q

PSGAG PK

A

route: Intra-articularly (IA) or IM
▪ No information is available

106
Q

PSGAG Adverse Effects

A

When used as labeled, it is safe
Associated with drug administration, i.e. / septic arthritis
Polysulfated glycosaminoglycan (PSGAG)

107
Q

Hyaluronate sodium (HS)
MOA?

A cushioning effect: reducing cell ________
Lubricating effect on the _______ ___ tissue
A scavenging effect: removes ____-derived free radicals

A

A cushioning effect: reducing cell migration
Lubricating effect on the articular soft tissue
A scavenging effect: removes O2-derived free radicals

108
Q

Hyaluronate sodium Uses?
Uses: To treat _______ that is associated with OA in dogs and horses
PK: No information is available in _____
Adverse effects: Transient ____ effects: ?

A

Uses: To treat synovitis that is associated with OA in dogs and horses
PK: No information is available in animals
Adverse effects: Transient local effects: swelling, heat

109
Q

Hyaluronate sodium PK

A

PK: No information is available in animals

110
Q

Hyaluronate sodium Adverse effects

A

Adverse effects: Transient local effects: swelling, heat

111
Q

Guidelines for the safe use of NSAIDs
▪ Individualized dosage based on the drug’s ________, ____ of the animal, and _________ of action
▪ Screen patients for underlying ______ and _______ dysfunction by performing ________ diagnostic procedures
▪ Monitor the _________ status of patients. __________ animals should not be places on NSAIDs before the hydration status is improved
▪ An adequate ______ ______ period should be allowed prior administrating a new NSAID
▪ Administer the _______ possible effective dose for the ______ period to minimize risk of injury
▪ Concurrent use of __________ and _______ should be avoided due to increased risk of GI complications

A

Guidelines for the safe use of NSAIDs
▪ Individualized dosage based on the drug’s efficacy, age of the animal, and duration of action
▪ Screen patients for underlying renal and hepatic dysfunction by performing routine diagnostic
procedures
▪ Monitor the hydration status of patients. Hypovolemic animals should not be places on NSAIDs
before the hydration status is improved
▪ An adequate wash out period should be allowed prior administrating a new NSAID
▪ Administer the lowest possible effective dose for the shortest period to minimize risk of injury
▪ Concurrent use of glucocorticoids and NSAIDs should be avoided due to increased risk of
GI complications

Intro to Pharmacology (31 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions